Yejin Mok, Aditya Surapaneni, Yingying Sang, Josef Coresh, Morgan E Grams, Kunihiro Matsushita, Shoshana H Ballew, Natalia Alencar de Pinho, Johan Ärnlöv, Sandhi M Barreto, Samira Bell, Hermann Brenner, Juan-Jesus Carrero, Rajkumar Chinnadurai, Elizabeth Ciemins, Ron T Gansevoort, Simerjot K Jassal, Keum Ji Jung, H Lester Kirchner, Tsuneo Konta, Csaba P Kovesdy, Li Luo, Krutika Pandit, Mahboob Rahman, Cassianne Robinson-Cohen, Charumathi Sabanayagam, Ulla T Schultheiss, Michael Shlipak, Natalie Staplin, Marcello Tonelli, Angela Yee-Moon Wang, Chi-Pang Wen, Mark Woodward, Jennifer S Lees
{"title":"慢性肾脏疾病和癌症风险:个体参与者数据荟萃分析","authors":"Yejin Mok, Aditya Surapaneni, Yingying Sang, Josef Coresh, Morgan E Grams, Kunihiro Matsushita, Shoshana H Ballew, Natalia Alencar de Pinho, Johan Ärnlöv, Sandhi M Barreto, Samira Bell, Hermann Brenner, Juan-Jesus Carrero, Rajkumar Chinnadurai, Elizabeth Ciemins, Ron T Gansevoort, Simerjot K Jassal, Keum Ji Jung, H Lester Kirchner, Tsuneo Konta, Csaba P Kovesdy, Li Luo, Krutika Pandit, Mahboob Rahman, Cassianne Robinson-Cohen, Charumathi Sabanayagam, Ulla T Schultheiss, Michael Shlipak, Natalie Staplin, Marcello Tonelli, Angela Yee-Moon Wang, Chi-Pang Wen, Mark Woodward, Jennifer S Lees","doi":"10.1038/s41416-025-03140-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.</p><p><strong>Methods: </strong>This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.</p><p><strong>Results: </strong>Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.</p><p><strong>Discussion: </strong>Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.</p>","PeriodicalId":9243,"journal":{"name":"British Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis.\",\"authors\":\"Yejin Mok, Aditya Surapaneni, Yingying Sang, Josef Coresh, Morgan E Grams, Kunihiro Matsushita, Shoshana H Ballew, Natalia Alencar de Pinho, Johan Ärnlöv, Sandhi M Barreto, Samira Bell, Hermann Brenner, Juan-Jesus Carrero, Rajkumar Chinnadurai, Elizabeth Ciemins, Ron T Gansevoort, Simerjot K Jassal, Keum Ji Jung, H Lester Kirchner, Tsuneo Konta, Csaba P Kovesdy, Li Luo, Krutika Pandit, Mahboob Rahman, Cassianne Robinson-Cohen, Charumathi Sabanayagam, Ulla T Schultheiss, Michael Shlipak, Natalie Staplin, Marcello Tonelli, Angela Yee-Moon Wang, Chi-Pang Wen, Mark Woodward, Jennifer S Lees\",\"doi\":\"10.1038/s41416-025-03140-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.</p><p><strong>Methods: </strong>This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.</p><p><strong>Results: </strong>Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.</p><p><strong>Discussion: </strong>Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.</p>\",\"PeriodicalId\":9243,\"journal\":{\"name\":\"British Journal of Cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41416-025-03140-z\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41416-025-03140-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:研究慢性肾脏疾病(CKD)与癌症风险的关系已经证明了相互矛盾的结果。方法:这是一项个体参与者数据荟萃分析,包括54个国际队列,为CKD预后协会做出贡献。纳入的队列有蛋白尿[尿白蛋白与肌酐比值(ACR)]、肾小球滤过率(eGFR)、总体和部位特异性癌症发病率以及确定的癌症危险因素的数据。纳入的参与者年龄在18岁或以上,以前没有癌症或肾衰竭。结果:在1319308名患者中,总体癌症发病率为17.3 / 1000人年。较高的ACR与癌症风险呈正相关[校正风险比为1.08 (95% CI 1.06-1.10) / ACR增加8倍]。eGFR与总体癌症风险没有关联。对于特定部位的癌症,较低的eGFR与泌尿系统癌和多发性骨髓瘤有关,而较高的ACR与许多类型的癌症(肾癌、头颈癌、结直肠癌、肝癌、胰腺癌、胆管癌、胃癌、喉癌、肺癌、血淋巴癌、白血病和多发性骨髓瘤)有关。1年里程碑分析的结果相似。讨论:蛋白尿,但不一定是eGFR,与随后的癌症风险独立相关。我们的结果保证了对解释蛋白尿和癌症之间联系的机制的调查。
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis.
Background: Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.
Methods: This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.
Results: Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.
Discussion: Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.
期刊介绍:
The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research.It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.